Global Helicobacter Pylori Testing Market – Industry Trends and Forecast to 2030

Helicobacter Pylori Testing Market Analysis and Size

The surging volume of patients suffering from gastric ulcers, the increasing prevalence of the senior population across the globe, the rising demand of point of care testing devices, increasing adoption of non-invasive testing, and easy availability of diagnostics tests are some of the major as well as vital factors which will likely to augment the growth of the helicobacter pylori testing market in the projected timeframe of 2023-2030. However, increasing advancement in technology, a rising number of innovations, and rising product approvals will further contribute by generating immense opportunities that will lead to the growth of the helicobacter pylori testing market in the abovementioned projected timeframe.

Data Bridge Market Research analyses that the helicobacter pylori testing market, which was USD 573.30 million in 2022, would rocket up to USD 993.19 million by 2030, and is expected to undergo a CAGR of 7.40% during the forecast period. This indicates that the market value. "Hospitals" dominates the end-user segment of the helicobacter pylori testing market owing to the increasing hospital cases. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Helicobacter Pylori Testing Market Scope and Segmentation

Market Definition

Aerobic, gram-negative bacteria mainly detected in the stomach are Helicobacter pylori (H. pylori). To maintain the stomach ecosystem, it plays a crucial role. H. infection with pylori is caused by spiral-shaped bacteria that invade the esophagus, small intestine, and stomach lining, contributing to gastric cancer, peptic ulcers, and chronic gastritis.

Global Helicobacter Pylori Testing Market Dynamics

Drivers

• An increasing number of cases of infectious diseases

The growth of Helicobacter pylori (H. pylori) cases are increasing due to factors such as the increasing number of cases of infectious diseases. Helicobacter pylori (H. pylori) is a bacterium that infects the stomach and is associated with various gastrointestinal disorders, such as peptic ulcer disease and gastritis. There are several methods for diagnosing H. pylori infection, such as breath, stool antigen, and rapid urease tests. H. pylori (Helicobacter pylori) is a type of bacteria that can infect the stomach and the small intestine. It is a common bacterial infection, with an estimated two-thirds of the world's population infected. In rare cases, H. pylori cause various gastrointestinal problems, including gastritis (stomach lining inflammation), peptic ulcers (sores in the stomach or duodenum), and even stomach cancer. Common symptoms of H. pylori infection include abdominal pain, nausea, vomiting, loss of appetite, and weight loss.

As per the journal published by the Cleveland Clinic Organization in September 2020, acute gastritis affects about 8 out of every 1,000 people in the U.S. annually. It also reported that chronic, long-term gastritis is less common and affects approximately 2 out of 10,000 people in the United States annually.

• Rising geriatric population

Expanding geriatric population worldwide is predicted to favor the Helicobacter pylori (H. pylori) cases as this population is more prone to develop diseases. The number of persons above 65 will double in the coming years. Old-age people are prone to various chronic diseases such as cardiovascular diseases, endovascular diseases, infectious diseases, and dental disorders, which can foster the demand for Helicobacter pylori (H. pylori) cases across the globe.

According to the United Nations, there were around 382 million people aged 60 years or above across the globe in 2017, expected to be 2.1 billion by 2050.

• Growing demand for non-invasive tests

Growing demand for non-invasive tests is expected to boost market growth. Patients prefer non-invasive diagnostic tests such as breath and stool antigen tests over invasive tests such as endoscopy. Thus, demand for non-invasive tests has driven the development of new diagnostic technologies, further fueling the growth during the helicobacter pylori diagnostics market forecast.

Moreover, the demand for helicobacter pylori diagnostics is not only limited to developed countries. Still, it is also being witnessed in developing countries, which will further act as a driver that will lead to the growth of the helicobacter pylori testing market in the abovementioned projected timeframe.

Opportunities

• Increase in technological advancements.

Key product launches, high concentration of market players or manufacturer's presence, and acquisition & partnerships among major players will extend profitable opportunities for the market players in the forecast period of 2023 to 2030. In addition, increasing technological advancement, a rising number of innovations, and rising product approvals will contribute by generating immense opportunities to expand the market's growth rate further.

Restraints/Challenges

• Unavailability of skilled professionals

The unavailability of skilled professionals and lack of awareness regarding the benefits of testing in developing economies will likely act as market restraints for the growth of the helicobacter pylori testing in the abovementioned projected timeframe. Moreover, competitive pricing pressure will become the biggest and foremost challenge for the market's growth in the forecast period of 2023-2030.

This helicobacter pylori testing market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the helicobacter pylori testing market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Development

• In June 2021, Biomerica Inc. announced that it had signed an exclusive five-year distribution agreement with a Canadian partner to distribute and market Biomerica's new and proprietary Helicobacter pylori test, called hp+detect. The hp+detect product has been developed for the identification and monitoring of helicobacter pylori infection, the leading cause of duodenal and gastric ulcers, and a contributing risk factor associated with gastric cancer.

Global Helicobacter Pylori Testing Market Scope

The helicobacter pylori testing market is segmented on the basis of test type, method, and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Test Type

• Invasive
• Histology
• Rapid Urease Test
• HP Culture
• Non-Invasive
• Serologic Test
• Urea Breath Test
• Stool Antigen Test

Method

• Point Of Care Testing
• Laboratory Based Testing

End User

• Hospitals
• Clinics
• Diagnostic Labs
• Others

Global Helicobacter Pylori Testing Market Regional Analysis/Insights

The helicobacter pylori testing market is analysed, and market size insights and trends are provided by country, test type, method, and end user.

The countries covered in the helicobacter pylori testing market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.  

North America is expected to dominate the helicobacter pylori testing market due to increasing consciousness about testing options, increasing technological advancement, and the prevalence of well-established healthcare infrastructure and geriatric population in the region.

Asia-Pacific is expected to grow at the highest growth rate during the forecast period of 2023 to 2030, owing to the increasing number of development in the testing sectors in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure growth Installed base and New Technology Penetration

The helicobacter pylori testing market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for helicobacter pylori testing market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the helicobacter pylori testing market. The data is available for historic period 2015-2020.

Competitive Landscape and Helicobacter Pylori Testing Market Share Analysis

The helicobacter pylori testing market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to the market.

Some of the major players operating in the helicobacter pylori testing market are:

• Bio-Rad Laboratories, Inc. (U.S.)
• Gulf Coast Scientific (U.S.)
• Thermo Fisher Scientific, Inc. (U.S.)
• Meridian Bioscience, Inc. (U.S.)
• Abbott (U.S.)
• Quidel Corporation. (U.S.)
• Cardinal Health. (U.S.)
• Avanos Medical Devices. (U.S.)
• Medline Industries, Inc. (U.S.)
• F. Hoffmann-La Roche Ltd (Switzerland)
• CorisBioconcept SPRL (Belgium)
• QIAGEN (Germany)
• Agilent Technologies, Inc. (U.S.)
• Helena Laboratories Corporation (U.S.)
• HORIBA Europe GmbH (Germany)
• Takara Bio Inc. (Japan)

SKU-57483